ScholarIQanswers from OpenAlex
Syndax Pharmaceuticals
FunderResearch funding and supported work
Syndax Pharmaceuticals is a funder indexed in ScholarIQ from OpenAlex.
What is known about Syndax Pharmaceuticals?
ScholarIQrecord summary
business
How many works does Syndax Pharmaceuticals have?
ScholarIQindexed works
Syndax Pharmaceuticals has 601 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Syndax Pharmaceuticals?
ScholarIQopenalex
The OpenAlex for Syndax Pharmaceuticals is on the source record.
What are the most-cited papers on Syndax Pharmaceuticals?
ScholarIQmost cited works
<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane, Kathryn C. Arbour, Joel W. Neal, Hatim Husain, Tracey L. Evans, Julie R. Brahmer, Alona Muzikansky, Philip Bonomi, Salvatore Del Prete, Anna Wurtz, Anna F. Farago, Dora Dias‐Santagata, Mari Mino–Kenudson, Karen L. Reckamp, Helena A. Yu, Heather A. Wakelee, Frances A. Shepherd, Zofia Piotrowska, Lecia V. Sequist
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick, Jean‐François Baurain, Anna V. Tinker, Hannelore Denys, Roisin E. O’Cearbhaill, Sakari Hietanen, Richard G. Moore, Anja Ør Knudsen, Thibault de La Motte Rouge, Florian Heitz, Tally Levy, Whitney York, Divya Gupta, Bradley J. Monk, Antonio González-Martı́n